BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2384277)

  • 1. Human T-cell leukemia virus type-I-infected T-cell lines scarcely produce p56lck, whether or not they express lck mRNA.
    Oh-Hori N; Koga Y; Yoshida H; Morita M; Kimura G; Nomoto K
    Int J Cancer; 1990 Aug; 46(2):315-9. PubMed ID: 2384277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of two lck transcripts directed from the distinct promoters in HTLV-I+ and HTLV-I- T-cells.
    Nakamura K; Koga Y; Yoshida H; Kimura G; Nomoto K
    Int J Cancer; 1991 Jul; 48(5):789-93. PubMed ID: 1712760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of transcription of lck (lymphocyte specific protein tyrosine kinase) message in IL-2-independent, HTLV-I-transformed T cell lines.
    Koga Y; Oh-Hori N; Sato H; Yamamoto N; Kimura G; Nomoto K
    J Immunol; 1989 Jun; 142(12):4493-9. PubMed ID: 2786034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transrepression of lck gene expression by human T-cell leukemia virus type 1-encoded p40tax.
    Lemasson I; Robert-Hebmann V; Hamaia S; Duc Dodon M; Gazzolo L; Devaux C
    J Virol; 1997 Mar; 71(3):1975-83. PubMed ID: 9032329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of p60lck in HTLV-I-transformed T cell lines detected by an anti-lck monoclonal antibody, MOL 171.
    Moroi Y; Koga Y; Nakamura K; Ohtsu M; Kimura G; Nomoto K
    Jpn J Cancer Res; 1991 Aug; 82(8):909-15. PubMed ID: 1910028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of transforming variants of the lck tyrosine protein kinase.
    Adler HT; Sefton BM
    Oncogene; 1992 Jun; 7(6):1191-9. PubMed ID: 1594248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells.
    Mills GB; Arima N; May C; Hill M; Schmandt R; Li J; Miyamoto NG; Greene WC
    Int Immunol; 1992 Nov; 4(11):1233-43. PubMed ID: 1472476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of interleukin 2-responsiveness in thymocytes of the transgenic mice carrying lck-transgene.
    Moroi Y; Koga Y; Nakamura K; Ohtsu M; Kimura G; Nomoto K
    Microbiol Immunol; 1993; 37(5):369-81. PubMed ID: 8102775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lck suppresses gene expression from various promoters including human T-cell leukemia virus type I promoter.
    Ohta M; Morita T; Shimotohno K
    Jpn J Cancer Res; 1990 May; 81(5):440-4. PubMed ID: 2116390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 independent transformation of a unique human T cell line, TY8-3, and its subclones by HTLV-I and -II.
    Yoshida T; Miyagawa E; Yamaguchi K; Kobayashi S; Takahashi Y; Yamashita A; Miura H; Itoyama Y; Yamamoto N
    Int J Cancer; 2001 Jan; 91(1):99-108. PubMed ID: 11149427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of p56lck, a lymphocyte specific protein tyrosine kinase, on the syncytium formation induced by human immunodeficiency virus envelope glycoprotein.
    Yoshida H; Koga Y; Moroi Y; Kimura G; Nomoto K
    Int Immunol; 1992 Feb; 4(2):233-42. PubMed ID: 1622897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic activation of the Lck protein accompanies translocation of the LCK gene in the human HSB2 T-cell leukemia.
    Wright DD; Sefton BM; Kamps MP
    Mol Cell Biol; 1994 Apr; 14(4):2429-37. PubMed ID: 8139546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of two classes of lck transcripts upon phorbol ester treatment of human leukemic T cells.
    Leung S; Miyamoto NG
    J Cell Physiol; 1991 Sep; 148(3):344-52. PubMed ID: 1918168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine T-lymphocyte proliferation induced by interleukin 2 correlates with a transient increase in p56lck kinase activity and the tyrosine phosphorylation of a 97-kDa protein.
    Kim YH; Buchholz MJ; Nordin AA
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3187-91. PubMed ID: 7682694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the T-cell receptor-mediated signal transduction by microinjection of anti-Lck monoclonal antibody into T-cells.
    Nakamura K; Koga Y; Yoshida H; Tanaka K; Sasaki M; Kimura G; Nomoto K
    Biochim Biophys Acta; 1994 Dec; 1224(3):495-505. PubMed ID: 7803509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of lck mRNA by T cell activation involves transcriptional and post-transcriptional mechanisms.
    Paillard F; Vaquero C
    Nucleic Acids Res; 1991 Sep; 19(17):4655-61. PubMed ID: 1832493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line.
    Karnitz L; Sutor SL; Torigoe T; Reed JC; Bell MP; McKean DJ; Leibson PJ; Abraham RT
    Mol Cell Biol; 1992 Oct; 12(10):4521-30. PubMed ID: 1406641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains.
    Veillette A; Caron L; Fournel M; Pawson T
    Oncogene; 1992 May; 7(5):971-80. PubMed ID: 1570157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck.
    Horak ID; Gress RE; Lucas PJ; Horak EM; Waldmann TA; Bolen JB
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1996-2000. PubMed ID: 2000405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase activity of CD4-associated p56lck may not be required for CD4-dependent T-cell activation.
    Collins TL; Burakoff SJ
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11885-9. PubMed ID: 7505449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.